The pathogenic roles of type I IFNs in several autoimmune diseases, and especially systemic lupus erythematosus (SLE), are well established, as documented by the appearance of an IFN‐related gene signature in peripheral blood (PB) concomitantly with disease reactivation.4 The gene discussed is IFNA1; the disease is systemic lupus erythematosus.